Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for ESTEVE PHARMACEUTICALS, S.A. · Pharmaceutical manufacturer of highly specialized medicines in areas of a high unmet need.

 Filing Registration
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Mar 23, 2026
Money reported
None
Registrations and no-activity reports carry no figure.

Official filing document

 Lobbyists on this filing 1
  • BOBBY MCMILLIN New on this filing
    Previously held: General Counsel, Senate Health, Education, Labor, & Pensions (HELP) Committee (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 2
Health Issues

Issues related to reimbursement and coverage for certain drugs.

Medicare/Medicaid

Issues related to reimbursement and coverage for certain drugs.

 Foreign interests disclosed 3

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

  • ESTEVE HEALTHCARE, S.L.
    Spain · 08038 Barcelona · owns 100% of the client · contributed $0.00
  • GRUPO ESTEVE LIFESCIENCES, S.L. (MAJORITY OWNER OF ESTEVE HEALTHCARE, S.L.)
    Spain · 08038 Barcelona · owns 74% of the client · contributed $0.00
  • LUBEA CATAMAN GMBH & CO.KG (MINORITY OWNER OF ESTEVE HEALTHCARE, S.L.)
    Germany · 22848 Norderstedt · owns 26% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem